Sign in Sign up for free

Theratechnologies Gross margin

What is the Gross margin of Theratechnologies?

The Gross margin of Theratechnologies, Inc. is 75.99%

What is the definition of Gross margin?



Gross margin is the difference between revenue and cost of goods sold, divided by revenue, and expressed as a percentage.

lfy (last fiscal year)

Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.

Gross margin of companies in the Health Care sector on TSX compared to Theratechnologies

What does Theratechnologies do?

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.

Companies with gross margin similar to Theratechnologies